nalmefene hydrochloride
Purdue Pharma vow not to profit from fast tracked opioid overdose antidote
March 18, 2019Sales and Marketing FDA, OxyContin, Purdue Pharma, nalmefene hydrochloride, opioids
The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection. However, …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
